Toxoplasmosis Infection During Pregnancy

Yazarlar

Özet

Toxoplasmosis is the most common congenital parasitic infection. The birth prevalence of congenital toxoplasmosis varies between 1 and 10 in 10,000 live births. While 74-81% of infected fetuses have only subclinical infection, up to 19-26% develop fetal/childhood disease even with treatment. Fetuses with congenital toxoplasmosis usually appear normal on prenatal ultrasound. Ultrasonographic findings suggestive of congenital disease include intracranial calcifications, ventriculomegaly, hepatic enlargement, ascites, and increased placental thickness. Neonatal clinical manifestations of congenital toxoplasmosis are highly variable. They include hydrocephalus, microcephaly, intracranial calcifications, chorioretinitis, strabismus, blindness, epilepsy, psychomotor or mental retardation, petechiae due to thrombocytopenia, and anemia. The classic triad of chorioretinitis, hydrocephalus, and cerebral calcifications is extremely rare. None of the findings described in neonates with congenital disease are pathognomonic of toxoplasmosis and may mimic congenital infection with other pathogens, such as cytomegalovirus, herpes simplex virus, rubella, and syphilis.
Diagnosis is usually confirmed by toxoplasma DNA PCR from amniocentesis material after 18 weeks of gestation. Prevention has been shown to reduce the incidence of disease and remains the most important intervention. A more careful follow-up process can be established by careful monitoring of ultrasonographic markers.

Referanslar

Neonatal Serologic Screening and Early Treatment for Congenital Toxoplasma gondii Infection | New England Journal of Medicine [İnternet]. [a.yer 08 Mart 2025]. Erişim adresi: https://www.nejm.org/doi/full/10.1056/nejm199406303302604

Thiébaut R, Leproust S, Chêne G, Gilbert R. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data. The Lancet. Ocak 2007;369(9556):115-22.

Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 12 Haziran 2004;363(9425):1965-76.

Ahmed M, Sood A, Gupta J. Toxoplasmosis in pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 01 Aralık 2020;255:44-50.

Remington JS, Thulliez P, Montoya JG. Recent Developments for Diagnosis of Toxoplasmosis. J Clin Microbiol. Mart 2004;42(3):941-5.

Anand R, Jones CW, Ricks JH, Sofarelli TA, Hale DC. Acute primary toxoplasmosis in travelers returning from endemic countries. J Travel Med. 2012;19(1):57-60.

Cortina-Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, vd. Prenatal Treatment for Serious Neurological Sequelae of Congenital Toxoplasmosis: An Observational Prospective Cohort Study. PLoS Med. 12 Ekim 2010;7(10):e1000351.

Fetal toxoplasmosis: ultrasonographic signs - Hohlfeld - 1991 - Ultrasound in Obstetrics & Gynecology - Wiley Online Library [İnternet]. [a.yer 08 Mart 2025]. Erişim adresi: https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1046/j.1469-0705.1991.01040241.x

Paquet C, Yudin MH, Allen VM, Bouchard C, Boucher M, Caddy S, vd. Toxoplasmosis in Pregnancy: Prevention, Screening, and Treatment. Journal of Obstetrics and Gynaecology Canada. 01 Ocak 2013;35(1):78-9.

Goldstein EJC, Montoya JG, Remington JS. Management of Toxoplasma gondii Infection during Pregnancy. Clinical Infectious Diseases. 15 Ağustos 2008;47(4):554-66.

Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis. 15 Şubat 2002;185 Suppl 1:S73-82.

Gras L, Gilbert RE, Wallon M, Peyron F, Cortina-Borja M. Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies. Epidemiol Infect. Haziran 2004;132(3):541-8.

Hedman K, Lappalainen M, Seppäiä I, Mäkelä O. Recent Primary Toxoplasma Infection Indicated by a Low Avidity of Specific IgG. The Journal of Infectious Diseases. 01 Nisan 1989;159(4):736-40.

Londoño-Martinez JC, Velasco-Velasquez S, Cordero-Lopez S, Osorio MF, Celis-Giraldo D, Thibodeau J, vd. Evaluation of the acceptability of point of care diagnostic test for prenatal toxoplasmosis (translational research phase III). Journal of Infection and Public Health. 01 Ocak 2023;16(1):15-24.

Sterkers Y, Pratlong F, Albaba S, Loubersac J, Picot MC, Pretet V, vd. Novel Interpretation of Molecular Diagnosis of Congenital Toxoplasmosis According to Gestational Age at the Time of Maternal Infection. J Clin Microbiol. Aralık 2012;50(12):3944-51.

Romand S, Wallon M, Franck J, Thulliez P, Peyron F, Dumon H. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol. Şubat 2001;97(2):296-300.

Maldonado YA, Read JS, COMMITTEE ON INFECTIOUS DISEASES. Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States. Pediatrics. 01 Şubat 2017;139(2):e20163860.

Mandelbrot L, Kieffer F, Sitta R, Laurichesse-Delmas H, Winer N, Mesnard L, vd. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial. Am J Obstet Gynecol. Ekim 2018;219(4):386.e1-386.e9.

Practice bulletin no. 151: Cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy. Obstet Gynecol. Haziran 2015;125(6):1510-25.

Khalil A, Sotiriadis A, Chaoui R, da Silva Costa F, D’Antonio F, Heath P t., vd. ISUOG Practice Guidelines: role of ultrasound in congenital infection. Ultrasound in Obstetrics & Gynecology. 2020;56(1):128-51.

Guerina NG, Hsu HW, Meissner HC, Maguire JH, Lynfield R, Stechenberg B, vd. Neonatal Serologic Screening and Early Treatment for Congenital Toxoplasma gondii Infection. New England Journal of Medicine. 30 Haziran 1994;330(26):1858-63.

Cook, A. J. C., et al. “Sources of toxoplasma infection in pregnant women: European multicentre case-control studyCommentary: Congenital toxoplasmosis—further thought for food.” Bmj 321.7254 (2000): 142-147.

Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, vd. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ. 15 Temmuz 2000;321(7254):142-7.

Kieffer F, Wallon M. Congenital toxoplasmosis. Handb Clin Neurol. 2013;112:1099-101.

Yayınlanan

16 Nisan 2025

Lisans

Lisans